News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
Biotech/Pharma - Alliances (World)
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014
China Cord Blood Corporation And Cordlife Group Limited Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy 7/23/2014
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014
ICON And University of Cambridge Collaborate To Deliver Educational Programme On Pricing & Market Access Strategy 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
The Medicines Patent Pool Signs A Record Seven New Sub-Licences To Speed The Availability Of Generic HIV Medicines To Developing Countries 7/17/2014
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014
Eli Lilly and Company (LLY) Inks $45 Million Immunotherapy Development Deal With Immunocore Limited 7/16/2014
Novartis AG (NVS) To Test Alzheimer's Drugs In Patients Without Symptoms 7/15/2014
Novartis AG (NVS), Google Inc. Strike Smart Contact Lenses Pact 7/15/2014
Harlan Laboratories, Inc. And Fluofarma Sign Strategic Collaboration Agreement 7/15/2014
Geisinger Health System And Indivumed Inc. Partner For Personalized Medicine Initiative 7/15/2014
Hovione And Merrion Pharmaceuticals, Inc. Announce Strategic Partnership On Use Of Merrion's GIPET Technology 7/15/2014
LEO Pharma & Klox Technologies Strike Global Dermatology Deal 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Hemispherx Biopharma (HEB) And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine 7/14/2014
Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. (JNJ) 7/14/2014
Collaboration Between Glatt And Innopharma Labs For Real-Time In-Line Particle Characterisation In Batch / Continuous Production 7/10/2014
HD Biosciences Co., Ltd And Marshall University School of Medicine Reach Drug Discovery Co-Development Agreement 7/10/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
AstraZeneca PLC (AZN), Max Planck Institute To Create Satellite Chemistry Unit 7/9/2014
Lightlake Therapeutics Inc. (LLTP) Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment 7/9/2014
Protea Biosciences, Inc. And Insphero AG Enter Into Collaboration And Co-Marketing Agreement To Combine 3D Technologies 7/9/2014
uniQure And Medison Pharma Ltd. Sign Glybera® Distribution Agreement For Israel 7/9/2014
Incyte Corporation (INCY) Grabs $25 Million Milestone From Novartis AG (NVS) 7/8/2014
PHT Corporation Selects Google Inc. Nexus Android Smartphone For Logpad® System Use In Clinical Research Programs 7/8/2014
Evotec AG (EVTG.F) To Collaborate With Fraunhofer In Joint Drug Discovery Programmes 7/8/2014
Genmab A/S (GEN.CO) Reaches USD 25 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 7/7/2014
Cliniworks Forms A Strategic Alliance With Pfizer Inc. (PFE) To Develop A Population Health Management Platform With Advanced Analytics And Patient Care Capabilities 7/7/2014
Yabao Pharmaceuticals Enters Innovative Partnership With Eli Lilly and Company (LLY) To Develop Diabetes Treatment 7/7/2014
Compugen Ltd. (CGEN) Discloses Achievement Of Milestone In Cancer Immunotherapy Collaboration With Bayer HealthCare (BAY) 7/7/2014
Sanofi (France) (SAN.PA) Raises Stake In Regeneron Pharmaceuticals, Inc. (REGN) 7/3/2014
UCB Group (UCBJF.PK) And Dermira Enter Into Strategic Collaboration In Dermatology To Broaden Patient Access To Cimzia® (Certolizumab Pegol) 7/3/2014
CureVac GmbH, Sanofi (France) (SAN.PA) Strike €150.5 Million+ Vaccine Pact 7/1/2014
First Licensing Deals For Stem Cell Company Accellta 7/1/2014
Biohit And Giraffes Pharmaceuticals Co. To Sign An Acetium Distribution Agreement 7/1/2014
Helsinn Group And Gen Ilac Establish A Collaboration For Anamorelin In Turkey 6/30/2014
VirtualScopics, LLC Signs An Alliance Framework Agreement With IXICO Plc; Commercial And Operational Alliance To Provide Clinical Trials Industry With Global Capabilities And A Full Range Of Therapeutic Areas And Modality Expertise 6/27/2014
Debiopharm And Nobelex Biotech Start Two Collaborations On Development Of New Antibiotics Against N. Gonorrhoeae And Enteric Species 6/26/2014
Cambridge-Based Mersana Therapeutics, Inc. Strikes New Oncology Pact Worth $792 Million With Merck KGaA (MKGAF.PK) 6/25/2014
Marcomm Systems Group And Corcanna Group Strike Strategic Partnership Deal To Aid Medical Marijuana Producers 6/25/2014
Bionomics Limited (BNO.AX) Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. (MRK) Worth Up To $526 Million 6/24/2014
Aurigene Discovery Technologies Limited And Orion Corporation Announce Research, Collaboration And Option Agreement For Rights To Aurigene's Epigenetics Program For Pan BET And Selective BET Bromodomain Inhibitors 6/24/2014
Ferring Pharmaceuticals, Roche (RHHBY) Partner Up To Make Personalised Infertility Treatment Possible 6/24/2014
Cook Pharmica LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform 6/24/2014
Agreement On Phase 3 Trial Protocol Of OSE Pharma's OSE-2101 From The FDA And European Medicines Agency 6/24/2014
Sanofi (France) (SAN.PA) Throws Cancer Drug Back To Merrimack Pharmaceuticals Inc. (MACK) 6/23/2014
China Biologic Products Announces Favorable Reduction In Value Added Tax Rate 6/23/2014
Servier And miRagen Therapeutics Extend Collaboration For The Research, Development And Commercialization Of Microrna-Targeting Drugs For Cardiovascular Disease 6/23/2014
Major Drugmakers Like AstraZeneca PLC (AZN), GlaxoSmithKline (GSK). And Johnson & Johnson (JNJ) Link Up With Academia In Huge $27 Million UK Dementia Project 6/20/2014
French Biotech Cellectis (ALCLS) Surges As Pfizer Inc. (PFE) Signs Cancer Immunotherapy Pact Worth $265 Million 6/19/2014
Endocyte, Inc. (ECYT) Plummets After Merck & Co., Inc. (MRK) Backs Out Of Drug Development Deal; Stock Down -13.99% At Market Close (June 18, 2014) 6/19/2014
CEA-Leti And Akrivis Technologies To Develop Nanomedicine Platform For High Payload Targeted Drug Delivery 6/19/2014
Evotec AG (EVTG.F) Receives Milestone Payment As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 6/19/2014
NicOx SA (COX.PA) And Sequenom Inc. (SQNM) Announce The Launch Of Expanded Access To Retnagene™ Test Portfolio In The U.S. 6/19/2014
uniQure And Medison Pharma Ltd. Sign Glybera Distribution Agreement For Israel 6/18/2014
3SBio Inc. (SSRX) Exclusively Licenses Pegsiticase (Uricase PEG-20) To Selecta Biosciences, Inc. To Develop Drug Candidate To Treat Gout 6/18/2014
Sanofi (France) (SAN.PA), Medtronic, Inc. (MDT) Team Up To Develop New Diabetes Devices 6/17/2014
Merck KGaA (MKGAF.PK) Terminates Multiple Schlerosis Drug License Agreement With Ono Pharmaceutical Company, Ltd. 6/17/2014
Biopas And moksha8 Announce Strategic Alliance To Commercialize Specialty Pharmaceuticals Across Latin America 6/16/2014
DrugDev Announces CFS Clinical Achieves Unprecedented $1 Billion Milestone in Global Investigator Payments 6/16/2014
Allenex AB Release: Three New Products Will Be Launched Globally 6/13/2014
AstraZeneca PLC (AZN) Beefs Up Pipeline With $232 Million Synairgen plc Asthma Deal 6/12/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Joins Johnson & Johnson (JNJ)'s Janssen Research & Development To Develop Single-Pill HIV Drug 6/12/2014
MorphoSys AG And Merck Serono Enter Strategic Immuno-Oncology Collaboration 6/12/2014
Parion Sciences Announces Exclusive Option Agreement For The Development And Commercialization Of P-321 In Ophthalmology In Certain Asian Territories 6/12/2014
RuiYi (formerly Anaphore) And iHuman Institute Form Collaboration To Identify Novel Antibodies Targeting GPCRs 6/11/2014
Isis Pharmaceuticals, Inc. (ISIS) Pockets $15 Million From AstraZeneca PLC (AZN) On ISIS-ARRx Study Initiation 6/10/2014
Biochrom Ltd. And Gilson, Inc. Sign Distribution Agreement To Deliver Automated ELISAs 6/10/2014
Beactica Initiates Drug Discovery Collaboration With Medivir AB (MVRBF) 6/10/2014
Shuwen Biotech And DiagnoCure (CUR) Sign Exclusive License And Collaboration Agreement For Commercializing Previstage™ GCC Colorectal Cancer Staging Test In China 6/5/2014
Cegedim SA Relationship Management Partners With Scribe Software To Enable Platform Connectivity 6/5/2014
LALREAN, A Latin American Network Of Excellence For The Study Of Liver Diseases, Enters Into A Collaboration With Advanced Biological Laboratories SA (ABL) To Enhance Regional Understanding Of The Burden Of Hepatitis C In Latin America 6/5/2014
INVISTA And EUCODIS Bioscience To Collaborate On Development Of Enzymes For The Production Of Industrial Chemicals 6/5/2014
arGEN-X Inks Long-Term Alliance With Shire Pharmaceuticals (SHPG) Worth $20.4 Million 6/4/2014
GW Pharmaceuticals Announces Agreement With New York State To Investigate Use Of CBD To Treat Medication-Resistant Epilepsies In Children 6/4/2014
Genmab A/S (GEN.CO) Announces Duobody And Hexabody Platform Collaboration With Undisclosed Biotechnology Company 6/4/2014
Beijing Institute of Genomics And Zixin Pharmaceutical Industrial Announce China-Developed Genomics Sequencer 6/3/2014
Cambridge Research Biochemicals And Key Organics Announce An Exclusive Global Supply & Marketing Agreement For Peptides 6/3/2014
Foamix Announces Collaboration With National Institutes of Health (NIH) 6/3/2014
Adaptimmune Ltd., GlaxoSmithKline (GSK) Strike $350 Million Cancer Immunotherapy Pact 6/2/2014
Bayer AG (BAYZF) Pays $68 Million Upfront For Orion Corporation's Prostate Cancer Candidate ODM-201 6/2/2014
EBD Group And Current Partnering Form Strategic Collaboration 6/2/2014
Advanced Biological Laboratories SA (ABL) And RDI Collaborate To Enhance HIV Patient Management 6/2/2014
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) And U.S.-Based Merck & Co., Inc. (MRK) To Collaborate On Companion Diagnostic Test For Analysis Of Tumor PD-L1 Levels 5/30/2014
NicOx SA (COX.PA): Santen, Inc. Grants EuPharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy 5/30/2014
QIAGEN N.V. (QGEN) And Eli Lilly and Company (LLY) Collaborate To Co-Develop Companion Diagnostics For Simultaneous Analysis Of Dna And Rna Biomarkers In Common Cancers 5/30/2014
Novozymes Biopharma Enters Agreement With A Leading Vaccine Company To Conduct Research On A Novel Subunit Vaccine Complex Based On Albumin Fusion Technology 5/29/2014
uniQure And Medison Pharma Ltd. Sign Glybera® Distribution Agreement For Israel 5/29/2014
EffRx Signs Binosto® Distribution Agreements In Russia And Africa 5/28/2014
Celerion And Korean Drug Development Fund Form Collaboration To Strengthen Early Phase Clinical Research In South Korea 5/28/2014
NicOx SA (COX.PA): Santen Grants Eupharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy 5/28/2014
Orient Europharma Co., Ltd. And Debiopharm Announce Their Partnership And The Launch Of Pamorelin®LA In Singapore 5/27/2014
MacroGenics, Inc. (MGNX) And Takeda Pharmaceutical Co. Ltd. (TKPYY) Enter Strategic Alliance To Develop DART For Treatment Of Autoimmune Disorders 5/27/2014
Targos Molecular Pathology GmbH And WuXi PharmaTech Co., Ltd. To Collaborate In Clinical Biomarker Services And Pathology Training In China 5/23/2014
Wilex AG (WL6.DE) Sends Back Some Promising Drugs To UCB, Inc. (UCBJF.PK) In Effort To Stay Alive 5/22/2014
Ophthotech Corporation (OPHT) May Pocket $1 Billion From Eye Drug Deal With Novartis AG (NVS), Ophthotech Stock Up +24.48% At Market Close (May 20, 2014) 5/20/2014
Orexo AB (ORXOF) Announces New Partner For The Commercialization Of Zubsolv® In The United States 5/20/2014
Cambridge Research Biochemicals Renews Supply Contract With The Medical Research Council For A Fourth Year 5/20/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Partners With Wipro To Enable A Global “As-A-Service” IT Platform 5/19/2014
Ardelyx Inc. Receives $25 Million Milestone From AstraZeneca PLC (AZN) For Commencement Of Phase 2b Clinical Trial Of Tenapanor 5/15/2014
MRC Technology And Daiichi Sankyo, Inc. (4568.t) Collaborate To Identify Novel Targets For Drug Discovery 5/14/2014
ENTERTECH SYSTEMS And Paxton Deliver Next-Generation Biometric Access Control To The UK With Suprema Technology 5/14/2014
NeoStem, Inc. Out-Licenses China Rights For Cancer Immunotherapy To Cellular Biomedicine Group 5/14/2014
CSPC Pharmaceutical Group Out-Licenses Western Rights For Cancer Drug To Dexcel 5/13/2014
DBV Technologies Announces Clinical Trial Agreement To Develop A Treatment For Milk-Induced Eosinophilic Esophagitis In Children 5/13/2014
Novozymes Biopharma To Offer Drug-Albumin Conjugation Platform In Collaboration With Thiologics 5/13/2014
Artemis CCD Ltd Announces New Distribution Partner 5/13/2014
ASLAN Pharmaceuticals Pte Ltd In-Licenses Novel Asthma Therapy From CSL Limited (CMXHF.PK) 5/13/2014
Lannett Company, Inc. (LCI) And HEC Pharm Announce U.S.-China Drug Distribution/CMO Plans 5/13/2014
In Pursuit Of Hot Autoimmune Target, GlaxoSmithKline (GSK) And Academics Team Up 5/12/2014
Pfizer Inc. (PFE) Announces Research Tie-Up With UK Universities 5/9/2014
University of Exeter Secures Pioneering AstraZeneca PLC (AZN) Partnership 5/9/2014
ScinoPharm And Lee's Pharmaceutical Jointly Develop A Number Of Drug Products For The Chinese Market 5/9/2014
AstraZeneca PLC (AZN) Seeks Partner For Potential $5 Billion Alzheimer's Blockbuster 5/8/2014
Cegedim SA Partners With Stratx For Innovative, Life Sciences-Specific Employee Training 5/8/2014
Janssen Announces Expanded Collaboration With International Partnership for Microbicides (IPM) For Development And Commercialization Of Dapivirine For Prevention Of Sexual Transmission Of HIV 5/8/2014
BeiGene Co.,Ltd Receives $5 Million Clinical Milestone Payment For Development Of BGB-283 5/7/2014
Euprotec Announces Collaboration With Cantab Anti-Infectives To Identify And Develop Novel Antibiotics 5/7/2014
United Therapeutics Corporation (UTHR)'s Lung Biotechnology Grabs $50 Million R&D Pact To Make Humanized Pig Organs 5/6/2014
Harbin Gloria Pharmaceuticals (002437.SZ) And Cumberland Pharmaceuticals (CPIX) In Translational R&D Partnership 5/6/2014
Evotec AG (EVTG.F) And Eternygen Enter Collaboration To Identify And Develop Novel Metabolic Disease Therapy 5/6/2014
Debiopharm And Yale University Extend And Broaden Their Collaboration For The Discovery And Development Of MIF Inhibitors To Treat Autoimmune And Inflammatory Diseases 5/6/2014
Cenix BioScience GmbH Signs Research Service Agreement With Bayer Pharma S.A. (TEVA) 5/5/2014
Cardiome Pharma Corp. (COM.TO) Announces Commercialization Agreement With UDG Healthcare plc For BRINAVESS™ In Ireland 5/5/2014
velixX GmbH & HSG-IMIT Collaboration For "Lab-On-A-Chip" Commercialization 5/2/2014
Novogen Limited (NVGN) And Genea Announce Partnership To Investigate Promising New Approach To Neurodegenerative Diseases 5/2/2014
Veracyte, Inc. (VCYT) And Fleury Announce Partnership To Make The Afirma® Gene Expression Classifier Available To Patients In Brazil 5/2/2014
Palatin Technologies (PTN) Announces Option Exercise By Specialty Pharmaceutical Company To License Bremelanotide In Europe 5/1/2014
Dolomite And Sphere Fluidics Partner To Deliver World Leading Droplet Based Technology 5/1/2014
Ambrx, Inc. And Zhejiang Hisun Pharmaceutical To Collaborate On The Development And Commercialization Of Bispecifics For Cancer 4/29/2014
TRANSGENE (ENX:TNG) Drops As Novartis AG (NVS) Decides To Pass On Bypass Drug; Stock Down -17.98% At Market Close (April 29, 2014) 4/29/2014
MorphoSys AG And Temple University Sign Therapeutic Antibody Discovery Partnership 4/29/2014
Pierre Fabre Selects Pierre Fabre Doccompliance To Manage Quality Documents Across Entire Organization 4/28/2014
Alimera Sciences (ALIM) Signs Specialised Therapeutics Australia As Exclusive Iluvien® Distributor For Australia, New Zealand 4/28/2014
Enzymotec Announces Signing Of Final Settlement And License Agreement With Neptune Technologies & Bioressources Inc. 4/28/2014
Sinovac Biotech Ltd. (SVA) Enters Technology Transfer Agreement With Intravacc To Develop And Commercialize Sabin Inactivated Polio Vaccine (Sipv) 4/28/2014
ALK-Abello A/S Enters Collaboration To Accelerate Growth In China 4/25/2014
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal 4/24/2014
Hydra Biosciences, Inc. And Boehringer Ingelheim Corporation Announce Worldwide Collaboration To Develop Small-Molecule Inhibitors For The Treatment Of Central Nervous System Diseases And Disorders 4/24/2014
Bristol-Myers Squibb Company (BMY) And Samsung Biologics Expand Manufacturing Agreement 4/23/2014
Vascular Solutions (VASC) Enters Into Agreement With US Army To Develop Freeze-Dried Plasma Product 4/23/2014
Sentinel Oncology And Oncothyreon Inc. (ONTY) Collaborate To Develop And Commercialise Small Molecule Chk1 Inhibitors 4/22/2014
Clinical Network Services Pty Ltd Contracted By Nuvilex For Clinical & Regulatory Support 4/22/2014
Bavarian Nordic (BAVA.CO) Announces Execution Of Option On Freeze-Dried IMVAMUNE 4/22/2014
AstraZeneca PLC (AZN) Opens Vast Library To Researchers But Gets First Dibs On New Drugs 4/17/2014
Mucosis B.V. Announces A Strategic Partnership With Changchun Bcht Biotechnology Of China And Raises Additional Capital 4/15/2014
Orflo And White Labs Sign Co-Marketing & Distribution Agreement 4/15/2014
Sanofi (France) (SAN.PA) Launches Probi Digestis® In Korea 4/15/2014
Zhejiang Hisun Pharma Enters Biosimilar Business With Catalent Pharma Solutions' Help 4/14/2014
Acura Pharmaceuticals, Inc. (ACUR) Walks Away From Pfizer Inc. (PFE) Licensing Pact 4/11/2014
Like MedImmune (AZN), GlaxoSmithKline (GSK) Takes Aim At Cancer In MD Anderson Cancer Center's Moon Shots Program 4/9/2014
DBV Technologies And CEA Conclude A Scientific Cooperation To Investigate Epigenetic Modulation In Epicutaneous Immunotherapy 4/9/2014
MediGene AG (MDGEF.PK) And Kora Healthcare Sign Agreement For The Commercialisation Of Veregen® In United Kingdom And Ireland 4/8/2014
MEDIAN Technologies Announces €422K Phase 2 Project Award 4/8/2014
Immutep S.A. And Eddingpharm (Cayman) Inc. Start Production Of Immufact® IMP321 At WuXi AppTec, Inc. In China 4/8/2014
ValiRx Plc Forms Risk-Sharing Joint Venture With Tangent Reprofiling Ltd 4/8/2014
Starpharma Holdings Ltd Partners With Bio-Pharmaceutical Giant AstraZeneca PLC (AZN) To Improve Cancer Treatment 4/7/2014
Medical Prognosis Institute And TD2 Join In Strategic Collaboration To Provide Drug Developers A Unique Multi Biomarker Direct Path To Drug Approval 4/3/2014
Auxogyn, Inc., Merck Serono Strike Eeva Test Pact 4/3/2014
TiGenix : Licenses Exclusive Marketing And Distribution Rights For Chondrocelect To Swedish Orphan Biovitrum 4/3/2014
Evotec AG (EVTG.F) And Debiopharm To Collaborate On Development Of New Treatment For Cancer 4/2/2014
AstraZeneca PLC (AZN) Strikes Unique Deal To Work Side-By-Side With Medical Research Council Scientists To Revitalize Pipeline, Spark Innovation 4/1/2014
BioAlliance Pharma Provides An Update On Its Partnerships For Loramyc®/Oravig® 4/1/2014
Croma – Pharma Announced The Signing Of A Significant Distribution Agreement With Asia´S Leading Producer Of Botulinum Toxins And Anti-Aging Products 4/1/2014
DBV Technologies Release: Additional Contribution To The Liquidity Agreement With Natixis 4/1/2014
Amarin Corporation PLC (AMRN) And Kowa Pharmaceuticals America Announce U.S. Co-Promotion Agreement For Vascepa® (Icosapent Ethyl) Capsules 4/1/2014
Texas A&M Agrilife Research And Gentegra LLC Are Awarded Contract Continuation 4/1/2014
AstraZeneca PLC (AZN) Forms Collaboration With Shenzhen University 3/31/2014
BioAlliance Pharma Collaborates With Penn Pharmaceutical Services On The Industrial Development Of Validive® 3/31/2014
Evotec AG (EVTG.F) And Convergence Pharmaceuticals Form Integrated Pain Alliance 3/31/2014
Gyros AB And Tekon Biotech Ltd. Sign Distribution Agreement 3/31/2014
H. Lundbeck A/S (LUN.CO) To Enter Into A Partnership With World-Renowned Research Institute 3/31/2014
Sanofi (France) (SAN.PA) And Awamedica Sign A Partnership Agreement For The Manufacturing Of Sanofi Products In Iraq 3/31/2014
Cardiome Pharma Corp. (COM.TO) Enters Agreement With Vianex To Commercialize BRINAVESS In Greece 3/28/2014
TopoTarget A/S Confirms Receipt Of Acceptance-To-File Milestone Payment 3/27/2014
Genmab A/S (GEN.CO) Reaches $22 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 3/27/2014
Ion Beam Applications (IBA) Signs Final Contract With Westdeutsches Protonentherapiezentrum Essen 3/26/2014
SIFI And NovaMedica Sign Agreement To Market Eight Eye Care Products In Russia 3/25/2014
Vectura Group plc (VEC.L) VR315 U.S. Development Milestone 3/25/2014
Ferrer Internacional Licenses Commercialisation Rights For Ozenoxacin In The United States To Medimetriks Pharmaceuticals, Inc. 3/24/2014
Austrianova (Austria) Contracted By Nuvilex For cGMP-Compliant Cell-In-A-Box® Encapsulation Of Cells 3/21/2014
BioTie Therapies Corp. To Regain Global Rights To Tozadenant From UCB Pharma (UCBJF.PK) 3/21/2014
Kinex Pharmaceuticals And Zenith Technology To Initiate Clinical Studies Of An Oral Form Of Paclitaxel (Oraxol) In New Zealand 3/20/2014
Astellas Pharma Inc. (ALPMY) And Daiichi Sankyo, Inc. (4568.t) Form Compound Library Sharing Partnership 3/20/2014
Eisai Company, Ltd. (ESALY.PK) Enters Collaboration With Liverpool School Of Tropical Medicine And University of Liverpool To Discover Novel Anti-Wolbachia Targeted Anti-Filarial Drugs 3/20/2014
Sanofi (France) (SAN.PA) Shells Out $23 Million Upfront To SK Chemicals Co. Ltd. For Pneumococcal Vaccine Pact 3/20/2014
BioAlliance Pharma Sitavig® Licensing Strategy Execution Of Licensing Agreement With Innocutis For North America 3/19/2014
Reach Announces Collaboration With Evotec AG (EVTG.F) 3/19/2014
Kimberly-Clark Corporation (KMB) And 3M Company (MMM) Announce U.S.-Based Infection Prevention Solutions Agreement 3/17/2014
Agilent Technologies Inc. (A) To Support National University of Singapore (NUS) Research Consortium To Identify, Map Lipid Levels In Healthy People 3/17/2014
Karo Bio AB To Be Awarded 1 Msek From Vinnova 3/17/2014
Meda AB (MEDA-A.ST) Enters Partnership For Elestrin In The US Market 3/14/2014
Alvotech And Finesse Solutions Announce Exciting Bio-Manufacturing Collaboration 3/13/2014
Novozymes Biopharma Announces Collaboration With Janssen Research & Development To Evaluate Proprietary VELTIS® Half-Life Extension Technology 3/13/2014
Ventana Medical Systems, Inc. (VMSI) And Bayer AG (BAYN.DE) Extend Collaboration 3/12/2014
Sanofi (France) (SAN.PA), UCB, Inc. (UCBJF.PK) Strikes $138 Million Pact To Seek Anti-Inflammatory Small Molecules 3/11/2014
WuXi PharmaTech Co., Ltd. And Pacific Biomarkers, Inc. Announce Collaboration 3/11/2014
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) And U.A.B. Advances In Their Program To Develop A Cure For Sanfilippo A Syndrome 3/11/2014